Calling 911 by reported demographic and overdose characteristics
| Variable | Number of (%) responses | Number of (%) called 911 n=89 | Number of (%) did not call 911 n=75 |
|---|---|---|---|
| Age (of person completing administration form) | 91 (100.00) | 50 (54.95) | 41 (45.05) |
| 20–30 | 29 (31.87) | 18 (62.07) | 11 (37.93) |
| 31–41 | 16 (17.58) | 8 (50.00) | 8 (50.00) |
| 42–46 | 23 (25.27) | 16 (69.57) | 7 (30.43) |
| 47–80 | 23 (25.27) | 8 (34.78) | 15 (65.22) |
| Sex (of person completing administration form) | 132 (100.00) | 72 (54.55) | 60 (45.45) |
| Male | 77 (58.33) | 36 (46.75) | 41 (53.25) |
| Female | 55 (41.67) | 36 (65.45) | 19 (34.55) |
| Health authority | 162 (100.00) | 88 (54.32) | 74 (45.68) |
| Vancouver Coastal Health | 67 (41.36) | 44 (65.67) | 23 (34.33) |
| Interior Health | 44 (27.16) | 10 (22.73) | 34 (77.27) |
| Fraser Health | 39 (24.07) | 27 (69.23) | 12 (30.77) |
| Island Health | 11 (6.79) | 7 (63.64) | 4 (36.36) |
| Northern Health | 1 (0.62) | 0 (0.00) | 1 (100.00) |
| Overdose setting | 158 (100.00) | 81 (51.27) | 77 (48.73) |
| Private residence | 80 (50.63) | 22 (27.50) | 58 (72.50) |
| On the street | 37 (23.42) | 30 (81.08) | 7 (18.92) |
| Hotel | 14 (8.86) | 8 (57.14) | 6 (42.86) |
| Other | 11 (6.96) | 7 (63.64) | 4 (36.36) |
| Shelter | 8 (5.06) | 8 (100.00) | 0 (0.00) |
| Supportive housing | 8 (5.06) | 6 (75.00) | 2 (25.00) |
| Programme period (weeks) | 150 (100.00) | 85 (56.67) | 65 (43.33) |
| <69.4 | 41 (27.33) | 19 (46.34) | 22 (53.66) |
| ≥69.4 | 109 (72.67) | 66 (60.55) | 43 (39.45) |
| Number of ampoules administered | 151 (100.00) | 82 (54.30) | 69 (45.70) |
| 1 | 86 (56.95) | 44 (51.16) | 42 (48.84) |
| 2 | 64 (42.38) | 37 (57.81) | 27 (42.19) |
| 3 | 1 (0.66) | 1 (100.00) | 0 (0.00) |
| Withdrawal symptoms | 139 (100.00) | 73 (52.52) | 66 (47.48) |
| None | 72 (51.80) | 45 (62.50) | 27 (37.50) |
| Mild | 47 (33.81) | 18 (38.30) | 29 (61.70) |
| Severe | 20 (14.39) | 10 (50.00) | 10 (50.00) |
| Aggression | 132 (100.00) | 75 (56.82) | 57 (43.18) |
| No | 105 (79.55) | 63 (60.00) | 42 (40.00) |
| Yes | 27 (20.45) | 12 (44.44) | 15 (55.56) |
| Number of substances involved | 158 (100.00) | 86 (54.43) | 72 (45.57) |
| 1 | 85 (53.80) | 48 (56.47) | 37 (43.53) |
| 2 | 50 (31.65) | 31 (62.00) | 19 (38.00) |
| 3 | 17 (10.76) | 3 (17.65) | 14 (82.35) |
| ≥4 | 6 (3.80) | 4 (66.67) | 2 (33.33) |
| Substances involved* | 158 (100) | – | – |
| Heroin | 142 (89.87) | 78 (54.93) | 64 (45.07) |
| Fentanyl | 35 (22.15) | 18 (51.43) | 17 (48.57) |
| Morphine | 11 (6.96) | 5 (45.45) | 6 (54.55) |
| Methadone | 9 (5.70) | 2 (22.22) | 7 (77.78) |
| Codeine | 4 (2.53) | 0 (0.00) | 4 (100.00) |
| Oxycodone | 4 (2.53) | 4 (100.00) | 0 (0.00) |
| Hydromorphone | 1 (0.63) | 0 (0.00) | 1 (100.00) |
| Methamphetamine | 16 (10.13) | 7 (43.75) | 9 (56.25) |
| Cocaine | 16 (10.13) | 5 (31.25) | 11 (68.75) |
| Alcohol | 16 (10.13) | 9 (56.25) | 7 (43.75) |
| Benzodiazepine | 6 (3.80) | 4 (66.67) | 2 (33.33) |
| GHB (gamma-hydroxybutyrate) | 1 (0.63) | 1 (100.00) | 0 (0.00) |
| Other | 2 (1.27) | 0 (0.00) | 2 (100.00) |
| Role | 164 (100.00) | 89 (54.27) | 75 (45.73) |
| Responded | 112 (68.29) | 64 (57.14) | 48 (42.86) |
| Not indicated | 52 (31.71) | 25 (48.08) | 27 (51.92) |
*Total numbers and percentages not shown for all columns as responses totalled more than 100% of participants.